Search Results 391-400 of 7502 for albumin

  1. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

    Serum albumin > 28 g/L - Lipase < 2 ULN - Urine protein/ creatinine ratio (UPCR) =< 1. Prothrombin time (PT)/ international normalized ratio (INR) and ...

  2. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

    Serum albumin ≥ 25 g/L (2.5 g/dL); For patients not receiving therapeutic anticoagulation: INR or aPTT ≤ 1.5 x ULN. For patients receiving therapeutic ...

  3. Chronic myelogenous leukemia - Symptoms and causes - Mayo Clinic

    Learn about chronic myelogenous leukemia symptoms and causes. Find out how CML is treated, including targeted therapy and bone marrow transplant.

  4. Amyloidosis - Diagnosis and treatment - Mayo Clinic

    This rare disease can affect different organs in different people. Find out how early and accurate diagnosis can lead to better outcomes.

  5. Advanced Product Incubator - Center for Regenerative Biotherapeutics - Mayo Clinic Research

    Mayo Clinic Center for Regenerative Biotherapeutics' Advanced Product Incubator allows development of off-the-shelf, cell-free regenerative therapies.

  6. Programs - Biliary Regenerative Medicine: Robert C. Huebert - Mayo Clinic Research

    The Biliary Regenerative Medicine Lab of Robert C. Huebert, M.D., includes research programs and a biobank containing stem cells from patients with liver ...

  7. Publications - Andrew R. Lewis, M.D. - Mayo Clinic

    Albumin-bilirubin grade as a prognostic indicator for patients with non-hepatocellular primary and metastatic liver malignancy undergoing Yttrium-90 ...

  8. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

    Platelet count ≥ 100,000/mm^3 (obtained ≤ 15 days prior to registration). Albumin ≥ 2.5 mg/dL (obtained ≤ 15 days prior to registration); Total bilirubin ...

  9. MEDI5395 Advanced Solid Tumors - Mayo Clinic

    Albumin < 3.5 g/dL;; Lactate dehydrogenase (LDH) > ULN;; Neutrophils-to-lymphocyte ratio (NLR) > 6;. Adequate organ function within 14 days of first dose of ...

  10. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Documented serum albumin <3 g/dL at Screening, and within 72 hours prior to first dose if first dose occurs more than 72 hours post screening (both labs at ...